747 related articles for article (PubMed ID: 10536138)
1. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D
Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138
[TBL] [Abstract][Full Text] [Related]
2. Targeted somatic mutagenesis in mouse epidermis.
Indra AK; Li M; Brocard J; Warot X; Bornert JM; Gérard C; Messaddeq N; Chambon P; Metzger D
Horm Res; 2000; 54(5-6):296-300. PubMed ID: 11595821
[TBL] [Abstract][Full Text] [Related]
3. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
4. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.
Brocard J; Warot X; Wendling O; Messaddeq N; Vonesch JL; Chambon P; Metzger D
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14559-63. PubMed ID: 9405652
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.
Feil R; Wagner J; Metzger D; Chambon P
Biochem Biophys Res Commun; 1997 Aug; 237(3):752-7. PubMed ID: 9299439
[TBL] [Abstract][Full Text] [Related]
6. Temporally controlled site-specific mutagenesis in the germ cell lineage of the mouse testis.
Weber P; Schuler M; Gérard C; Mark M; Metzger D; Chambon P
Biol Reprod; 2003 Feb; 68(2):553-9. PubMed ID: 12533419
[TBL] [Abstract][Full Text] [Related]
7. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase.
Metzger D; Clifford J; Chiba H; Chambon P
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6991-5. PubMed ID: 7624356
[TBL] [Abstract][Full Text] [Related]
8. Ligand-activated site-specific recombination in mice.
Feil R; Brocard J; Mascrez B; LeMeur M; Metzger D; Chambon P
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10887-90. PubMed ID: 8855277
[TBL] [Abstract][Full Text] [Related]
9. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.
Vasioukhin V; Degenstein L; Wise B; Fuchs E
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8551-6. PubMed ID: 10411913
[TBL] [Abstract][Full Text] [Related]
10. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
Hayashi S; McMahon AP
Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
[TBL] [Abstract][Full Text] [Related]
11. Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.
Bex A; Vooijs M; Horenblas S; Berns A
J Urol; 2002 Dec; 168(6):2641-4. PubMed ID: 12442001
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
[TBL] [Abstract][Full Text] [Related]
13. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice exhibiting inducible and spontaneous Cre activities driven by a bovine keratin 5 promoter that can be used for the conditional analysis of basal epithelial cells in multiple organs.
Liang CC; You LR; Chang JL; Tsai TF; Chen CM
J Biomed Sci; 2009 Jan; 16(1):2. PubMed ID: 19272176
[TBL] [Abstract][Full Text] [Related]
15. Temporally controlled somatic mutagenesis in smooth muscle.
Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
[TBL] [Abstract][Full Text] [Related]
16. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
17. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
Chiba H; Chambon P; Metzger D
Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
[TBL] [Abstract][Full Text] [Related]
19. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.
Sohal DS; Nghiem M; Crackower MA; Witt SA; Kimball TR; Tymitz KM; Penninger JM; Molkentin JD
Circ Res; 2001 Jul; 89(1):20-5. PubMed ID: 11440973
[TBL] [Abstract][Full Text] [Related]
20. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
Zhu HZ; Cao YY; Cheng GX; Xue JL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
